Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND …,

Once completing necessary clinical studies, YishengBio is to seek emergency use authorization (“EUA”) and approval to market PIKA recombinant …, Once completing necessary clinical studies, YishengBio is to seek emergency use authorization (“EUA”) and approval to market PIKA recombinant …, Read More

Scroll to Top